Thinking about buying stock in Immunitybio, Aurora Cannabis, Elutia, Canopy Growth, or Neubase Therapeutics?

OpGen Inc

Change company Symbol lookup

Select an option...

OPGN OpGen Inc

THAR Tharimmune Inc

KITT Nauticus Robotics Inc

EAT Brinker International Inc

JCSE JE Cleantech Holdings Ltd

GVP GSE Systems Inc

CURV Torrid Holdings Inc

APRN Blue Apron Holdings Inc

BXRX Baudax Bio Inc

LAC Lithium Americas Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

Thinking about buying stock in Immunitybio, Aurora Cannabis, Elutia, Canopy Growth, or Neubase Therapeutics?

9:31 am ET September 11, 2023 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for IBRX, ACB, ELUT, CGC, and NBSE.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- IBRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=IBRX&prnumber=091120230

-- ACB: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ACB&prnumber=091120230

-- ELUT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ELUT&prnumber=091120230

-- CGC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CGC&prnumber=091120230

-- NBSE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NBSE&prnumber=091120230

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG05644&sd=2023-09-11

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-immunitybio-aurora-cannabis-elutia-canopy-growth-or-neubase-therapeutics-301923311.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG05644&Transmission_Id=202309110931PR_NEWS_USPR_____CG05644&DateId=20230911

COMTEX_439967313/1005/2023-09-11T09:31:36